FutureTech II Acquisition Corp. Files Q1 2025 10-Q
Ticker: FTII · Form: 10-Q · Filed: May 20, 2025 · CIK: 1889450
Sentiment: neutral
Topics: 10-Q, quarterly-report, acquisition-corp, securities
TL;DR
**FTII files Q1 10-Q. Details on stock, warrants, and related parties.**
AI Summary
FutureTech II Acquisition Corp. filed its 10-Q for the period ending March 31, 2025. The company, operating in the Biological Products sector, reported on its Class A and Class B common stock, as well as redeemable warrants. Financial details and specific dollar amounts are not detailed in this header information.
Why It Matters
This filing provides an update on the financial status and corporate structure of FutureTech II Acquisition Corp., which is relevant for investors and stakeholders tracking the company's progress.
Risk Assessment
Risk Level: low — This filing is a standard quarterly report and does not contain immediate, high-impact financial distress signals.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the fiscal quarter covered by the report.)
- 20250520 — Filing Date (The date the report was officially submitted to the SEC.)
Key Players & Entities
- FutureTech II Acquisition Corp. (company) — Filer of the 10-Q
- 0001889450 (company) — Central Index Key for FutureTech II Acquisition Corp.
- 20250331 (date) — End of the reporting period
- 20250520 (date) — Filing date
- FTII:UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember (company) — Security type
- FTII:ClassCommonStock0.0001ParValuePerShareMember (company) — Security type
- FTII:RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember (company) — Security type
- us-gaap:CommonClassAMember (company) — Stock class
- us-gaap:CommonClassBMember (company) — Stock class
- FTII:SponsorMember (company) — Related party designation
FAQ
What is the primary business of FutureTech II Acquisition Corp. according to this filing?
FutureTech II Acquisition Corp. is classified under the SIC code 2836, which pertains to Biological Products (No Diagnostic Substances).
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is March 31, 2025.
When was this 10-Q filing submitted to the SEC?
The filing date was May 20, 2025.
What types of securities are mentioned in relation to FutureTech II Acquisition Corp. for the period ending March 31, 2025?
The filing mentions FTII:UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember, FTII:ClassCommonStock0.0001ParValuePerShareMember, and FTII:RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember.
Are there any specific dollar amounts mentioned for the reporting period in this header information?
No specific dollar amounts for the reporting period are detailed in the provided header information of the 10-Q filing.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 20, 2025 regarding FutureTech II Acquisition Corp. (FTII).